Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biospecifics Tech Cp (BSTC)

Biospecifics Tech Cp (BSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 650,252
  • Shares Outstanding, K 7,345
  • Annual Sales, $ 38,190 K
  • Annual Income, $ 24,470 K
  • 60-Month Beta 0.24
  • Price/Sales 17.00
  • Price/Cash Flow 26.22
  • Price/Book 4.81
Trade BSTC with:
  • Price/Earnings ttm 33.87
  • Earnings Per Share ttm 2.61
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/13/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.62
  • Number of Estimates 1
  • High Estimate 0.62
  • Low Estimate 0.62
  • Prior Year 1.00
  • Growth Rate Est. (year over year) -38.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
88.10 +0.49%
on 11/02/20
88.57 -0.05%
on 12/01/20
+0.43 (+0.49%)
since 10/30/20
3-Month
51.03 +73.50%
on 09/24/20
89.15 -0.70%
on 10/20/20
+26.29 (+42.24%)
since 09/01/20
52-Week
42.00 +110.79%
on 03/23/20
89.15 -0.70%
on 10/20/20
+33.53 (+60.96%)
since 11/29/19

Most Recent Stories

More News
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – BSTC, UROV, CXO

NEW YORK, NY / ACCESSWIRE / November 18, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: BioSpecifics Technologies Corp. (NASDAQ:BSTC) concerning potential violations...

BSTC : 88.53 (+0.15%)
UROV : 16.24 (+0.06%)
CXO : 65.60 (-6.02%)
BioSpecifics Merger Investigation: Halper Sadeh LLP Encourages BioSpecifics Technologies Corp. Shareholders to Contact the Firm – BSTC

NEW YORK, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating BioSpecifics Technologies Corp. (NASDAQ: BSTC) and its board of directors...

BSTC : 88.53 (+0.15%)
SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Investigations; Investors are Encouraged to Contact the Firm – BSTC, PE, PNM, CEIX

NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

PE : 16.93 (+3.17%)
PNM : 41.77 (-1.04%)
CEIX : 105.65 (unch)
BSTC : 88.53 (+0.15%)
Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout

WILMINGTON, Del., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A. announces that it is investigating BioSpecifics Technologies Corp. (“BioSpecifics”) (NASDAQ GM: BSTC ) regarding possible...

BSTC : 88.53 (+0.15%)
ENDP : 0.2926 (-5.00%)
SHAREHOLDER ALERT: Barr Law Group Investigating ZM, CBLI, BSTC, QSR; Shareholders are Encouraged to Contact the Firm

SAN DIEGO, Nov. 10, 2020 (GLOBE NEWSWIRE) -- National law firm Barr Law Group is investigating Zoom Video Communications, Inc., Cleveland BioLabs, Inc., BioSpecifics Technologies Corp., and Restaurant...

ZM : 68.30 (-0.03%)
CBLI : 3.17 (-7.31%)
BSTC : 88.53 (+0.15%)
QSR : 69.83 (-0.07%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – BSTC, CBLI, PE, GLIBA

NEW YORK, NY / ACCESSWIRE / November 7, 2020 /Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: BioSpecifics Technologies Corp. (NASDAQ:BSTC) concerning potential violations...

PE : 16.93 (+3.17%)
BSTC : 88.53 (+0.15%)
CBLI : 3.17 (-7.31%)
GLIBA : 91.73 (-2.57%)
ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm – CXO, BSTC, CBLI, PE

NEW YORK, Nov. 06, 2020 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:

CBLI : 3.17 (-7.31%)
PE : 16.93 (+3.17%)
BSTC : 88.53 (+0.15%)
CXO : 65.60 (-6.02%)
Moore Kuehn Encourages TNAV, PRCP, ALSK, and BSTC Investors to Contact Law Firm

NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning...

TNAV : 4.79 (unch)
PRCP : 6.98 (+0.07%)
ALSK : 3.40 (+0.29%)
BSTC : 88.53 (+0.15%)
Lifshitz Law Firm, P.C. Announces Investigation of BioSpecifics Technologies Corp., Cleveland BioLabs, Inc., Concho Resources Inc., and CONSOL Energy Inc.

NEW YORK, Nov. 04, 2020 (GLOBE NEWSWIRE) --

BSTC : 88.53 (+0.15%)
CBLI : 3.17 (-7.31%)
CXO : 65.60 (-6.02%)
CEIX : 105.65 (unch)
CCR : 4.73 (-4.25%)
BIOSPECIFICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of BioSpecifics Technologies Corp. - BSTC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of BioSpecifics Technologies Corp. (NasdaqGS:...

BSTC : 88.53 (+0.15%)
ENDP : 0.2926 (-5.00%)

Business Summary

BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 88.64
1st Resistance Point 88.59
Last Price 88.53
1st Support Level 88.46
2nd Support Level 88.38
3rd Support Level N/A

See More

52-Week High 89.15
Last Price 88.53
Fibonacci 61.8% 71.14
Fibonacci 50% 65.57
Fibonacci 38.2% 60.01
52-Week Low 42.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar